4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001628280-26-012390
Chief Executive Officer sold 14,762 shares at $9.53 ($140,720)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| De Backer Marianne Chief Executive Officer | 2026-02-24 | Sale 10b5-1 | −14,762 | $9.53 | $140,720 | 1,020,704 | D |
| Open-market sales · 14,762 sh · avg $9.53 · $140,720 | |||||||
Loading xslF345X05/wk-form4_1772142870.xml…